Alvio Pharmaceuticals Pvt. Ltd.

What Alvio Pharmaceuticals Pvt. Ltd. does

Alvio Pharmaceuticals Pvt. Ltd. is an Indian pharmaceutical marketing company headquartered in Ahmedabad, Gujarat, and operating as a subsidiary of Salud Care India Limited. Founded in its current form in 2016 following a restructuring of parent Salud Care (originally established in 2003), Alvio markets finished pharmaceutical formulations across four therapeutic segments: Dermatology & Cosmetology (brands Uncap and Rasavio), Cardiology & Chronic Care, Diabetology & Metabolic Care, and Nutraceuticals (RasaGlow). The portfolio spans 300+ molecules delivered through multiple dosage forms including tablets, capsules, liquids, ointments, nasal sprays, softgels, effervescent tablets, and sachets, with category-specific products ranging from rosuvastatin/atorvastatin and SGLT2/DPP4 inhibitors to NMN-based anti-aging creams and glutathione effervescent tablets. The company does not own manufacturing facilities directly but is supported by an integrated production ecosystem across three group entities: Salud Care India Limited (Roorkee, Uttarakhand; PIC/S-driven), Stelvio Healthcare (WHO-GMP, Ahmedabad), and Rebase Lifesciences (acquired 2023, softgel/effervescent specialist).

The company's go-to-market is built on a direct field sales model: 300+ trained field professionals engage 35,000+ healthcare professionals across 11+ Indian states including Gujarat, Maharashtra, West Bengal, Bihar, Assam, Telangana, Tamil Nadu, Jharkhand, Orissa, and Tripura. Revenue is generated through one-time sales of pharmaceutical formulations to channel partners and via physician-driven prescriptions, with no subscription, licensing, or platform model disclosed. Pricing is determined through direct B2B engagement with channel partners and is not publicly disclosed. The company is founder/family-owned (Dudhwewala family), privately held with no public listing, no external institutional funding, and no disclosed revenue figures. Marketing combines field detailing with content (Insights blog), LinkedIn, and Facebook. Recent strategic direction has emphasized category expansion into dermocosmetics and nutraceuticals, capacity expansion through inorganic moves (Rebase Lifesciences acquisition), and broader geographic penetration toward stated PAN-India coverage.

Name

Alvio Pharmaceuticals Pvt. Ltd.

Legal name

Alvio Pharmaceuticals Pvt. Ltd.

Website

https://alviopharma.com

Company type

Private

Founded year

2016

Operating status

Operating

Headcount range

51–100 employees

Short description

Alvio Pharmaceuticals is an Indian pharmaceutical marketing subsidiary of Salud Care India Limited, selling 300+ formulations across dermatology, cardiology, diabetology, and nutraceuticals via a 300+ person field force to 35,000+ healthcare professionals across 11+ states.

Ownership category

akta.pro rank

Product category

Pharmaceutical Formulations

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro industry

PRIMARYHLAIAAAE

Cardiometabolic Pharmaceuticals (Cardiovascular/Diabetes/Obesity)

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

SECONDARYHLAIAAAK

Dermatology & Aesthetics Pharmaceuticals

Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

• Pharmaceutical formulations
• Dermatology and cosmetology
• Cardiology chronic care
• Diabetology metabolic care
• Nutraceutical products

Headquarters

HQ city

Ahmedabad

HQ country

India

HQ region

Asia

Offices2 records

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Personnel, Supply Chain, Marketing or Sales, Technology or R&D, Operations, Infrastructure

Revenue model

1. Pharmaceutical Product Sales: Revenue generated from marketing and selling finished pharmaceutical formulations including tablets, capsules, liquids, ointments, dry powders, and nasal sprays across therapeutic segments including dermatology, cardiology, chronic care, and nutraceuticals. Products are distributed through field sales teams targeting healthcare professionals.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Core offering

Alvio Pharmaceuticals develops, markets, and distributes finished pharmaceutical formulations across Dermatology & Cosmetology (Uncap, Rasavio), Cardiology & Chronic Care, Diabetology & Metabolic Care, and Nutraceuticals (RasaGlow). The company markets these formulations through a 300+ strong field sales force reaching 35,000+ healthcare professionals across 11+ Indian states, supported by an integrated manufacturing ecosystem including Salud Care India Limited, Stelvio Healthcare, and Rebase Lifesciences.

Product overview

Alvio Pharmaceuticals is a pharmaceutical company offering a multi-brand portfolio of finished formulations across four therapeutic segments: Dermatology & Cosmetology (Uncap, Rasavio brands), Cardiology & Chronic Care (Cardiovascular division), Diabetology & Metabolic Care (Anti-Diabetes division), and Nutraceuticals (RasaGlow brand). The product portfolio includes topical creams, gels, cleansers, serums, moisturizers, sunscreens, shampoos, effervescent tablets, capsules, and oral medications. Key dermatology products include Advanced Age Repair Cream (NMN/stem cell), Anti-Acne PM Gel (Brazilian propolis), Ceramide+ Moisturizer, and Morning Bloom Anti-Acne Moisturizer. The nutraceutical range features Age Defying Tablets (NMN), RasaVit-S (collagen builder), and Radiance/Radiance+/Radiance Forte/Radiance Max (skin wellness). Cardiovascular products include ALVIROZ (rosuvastatin), ALVOTIN (atorvastatin), VISART (sacubitril/valsartan), and combination antiplatelet therapies. Anti-diabetes products include DAPCARD (dapagliflozin), EMZAVIO (empagliflozin), and combination metformin preparations. The company operates as an ethical marketing company backed by manufacturing partners Salud Care India Limited, Stelvio Healthcare, and Rebase Lifesciences.

Differentiator

Problem solved

Functional benefit

Brands

• Uncap: Dermatology & Cosmetology division focused on science-backed skincare solutions including anti-acne products, age-defying treatments, and cleansers.
• Rasavio
• RasaGlow
• Derma Care
• Cardio Care

Products and services

• Cardiovascular Portfolio (Cardio Care) Cardiology division offering cardiovascular medications including statins (e.g., rosuvastatin ALVIROZ, atorvastatin ALVOTIN), antihypertensives, antiplatelets, and heart failure treatments (e.g., sacubitril/valsartan VISART) targeted at cardiologists for chronic cardiovascular disease management.
• Anti-Diabetes Portfolio Diabetology division offering anti-diabetic medications including SGLT2 inhibitors (DAPCARD/dapagliflozin, EMZAVIO/empagliflozin), DPP4 inhibitors, and metformin combination formulations for type 2 diabetes management by diabetologists.
• Urology Portfolio Division offering urological medications including alpha-blockers and combination therapies for urological conditions.
• Chronic Supplements Portfolio Nutritional supplements for chronic disease management support as a complementary chronic-care offering.
• Uncap (Dermatology & Cosmetology brand) Science-backed skincare brand for acne-prone skin and anti-aging care, including anti-acne cleansers, PM gels, acne moisturizers, age-defying tablets/cleansers, and advanced age repair creams powered by NMN, stem cells, peptides, and ceramides. Targeted to dermatologists and patients seeking evidence-based skincare.
• Rasavio (Dermatology & Cosmetology brand) Skincare brand offering ceramide moisturizers, skin brightening treatments, under-eye care, hyperpigmentation management (RasaMom F), hair health (RasaVit-H), skin hydration (RasaVit-S), and antifungal products (RasaFin, Rasazing) targeted at dermatologists.
• RasaGlow (Nutraceutical brand) Nutraceutical brand for skin, hair, and nail wellness featuring antioxidant, glutathione, collagen, and biotin formulations including the Radiance effervescent-tablet range (Radiance, Radiance+, Radiance Forte, Radiance Max).

Segments3 records

Ideal customer profiles1 record

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Partnerships

Three partnerships are on record, tiered core and minor.

• Salud Care India LimitedcoreStrategic or Co-development PartnerPrimary manufacturing partner providing contract manufacturing services for high-quality finished pharmaceutical formulations. Company has been operating since 2006 with PIC/S-driven manufacturing standards. Supports Alvio's formulation requirements including tablets, capsules, liquids, and ointments with focus on affordability, consistency, and global compliance.
• Stelvio HealthcarecoreStrategic or Co-development PartnerR&D-driven manufacturing partner with WHO-GMP accredited facility in Ahmedabad, India. Supports wide range of therapeutic categories across oral solids, injectables, liquids, and nutraceutical/cosmeceutical products. Also handles international market reach through branded formulations and generics.
• Rebase Lifesciences Pvt. Ltd.minorStrategic or Co-development PartnerIntegrated pharmaceutical company acquired in 2023 to strengthen group capabilities. Specializes in softgel capsules, tablets, effervescent tablets, hard gelatin capsules, powders in sachets, and jellies for pharmaceutical and nutraceutical sectors. Provides differentiated products and reliable outsourcing solutions.

Scale indicators4 records

Recent moves8 records

Expansion highlights6 records

Direct peers

• Ajanta Pharma: Mid-size Indian pharma with strong dermatology and emerging chronic-care franchises sold through specialist channels. Comparable in therapeutic breadth and derma-cosmetics positioning.
• Torrent Pharmaceuticals: Established Indian pharma with a leading cardiometabolic franchise (chronic, cardiovascular, diabetology) and selective derma presence. Closely comparable core therapy mix and specialist GTM.
• Alkem Laboratories: Indian pharma with significant presence in cardiology, diabetology, and dermatology, supported by a large domestic field force. Comparable multi-therapeutic chronic-and-derma footprint.
• Eris Lifesciences: Indian specialty pharma focused on cardio-metabolic and chronic care with a specialist field force model. Closely comparable business model, therapy focus, and prescriber-driven GTM.
• Mankind Pharma: India's largest chronic-care focused pharma company with a strong field force across cardiology, diabetology, and derma-cosmetics. Most directly comparable peer in therapeutic focus, GTM model, and target prescriber base.
• Corona Remedies: Privately held mid-size Indian pharma focused on chronic care, gynecology, and derma with a field-force driven model. Comparable scale, ownership structure, and chronic-care focus.
• Micro Labs: Privately held Indian pharma with a broad portfolio across cardiology, diabetology, derma, and nutraceuticals, sold through a specialist field force. Closely comparable scale, ownership profile, and portfolio shape.

Broad incumbents

• Glenmark Pharmaceuticals: Indian pharma with strong dermatology franchise (including derma-cosmetics) and chronic-care presence. Comparable therapeutic overlap, though at meaningfully larger scale and geographic reach.
• Cipla: Diversified Indian pharma major with established derma-cosmetics and chronic care franchises. Overlaps with Alvio's therapy areas but competes from a much larger, more diversified base.
• Zydus Lifesciences (Cadila): Large Indian pharma incumbent with deep cardiometabolic, derma, and consumer wellness portfolios. Operates in the same therapy areas as Alvio but at materially larger scale and with broader reach.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights5 records

Customer concentration

• Facebookfacebook.com/alviopharma
• LinkedInlinkedin.com/company/alviopharma

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Alvio Pharmaceuticals Pvt. Ltd.